Research Article - (2014) Volume 2, Issue 5
Dissecting the In Vivo Leukemogenic Potency of Bclxl
- Kumar Saurabh1, Michael T Scherzer1,4, Amy Song1, Kenneth W Yip5,6, John C Reed5,6, Chi Li1,2,3 and Levi J Beverly1,2,3*
- 1James Graham Brown Cancer Center, University of Louisville, Louisville, KY 40202, USA
- 2Department of Medicine, Division of Hematology and Oncology, University of Louisville, School of Medicine, Louisville, KY 40202, USA
- 3Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40202, USA
- 4Department of Bioengineering, University of Louisville, Louisville, KY 40292, USA
- 5Sanford-Burnham Medical Research Institute, La Jolla, CA, 92037, USA
- 6Ontario Cancer Institute, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario M5G 2M9, Canada
*Corresponding Author:
Levi J Beverly, Department of Medicine, University of Louisville, 505 S. Hancock Street, CTRB Rm 204,Louisville, KY 40202, USA, Tel: 502-852-8968, Fax: 502-852-7979
Email:
